[1]梅丽军,王西强,崔倩卫,等.主动脉内球囊反搏在复杂高危有指征患者病变介入治疗中的临床应用研究[J].陕西医学杂志,2024,(2):231-234.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.018]
　MEI Lijun,WANG Xiqiang,CUI Qianwei,et al.Clinical study of intra-aortic balloon pump in interventional treatment of CHIP lesions[J].,2024,(2):231-234.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.018]
点击复制

主动脉内球囊反搏在复杂高危有指征患者病变介入治疗中的临床应用研究

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年2期
页码:
231-234
栏目:
临床研究
出版日期:
2024-02-05

文章信息/Info

Title:
Clinical study of intra-aortic balloon pump in interventional treatment of CHIP lesions
作者:
梅丽军1; 王西强2; 崔倩卫2; 祝 领2; 邢玉洁2
(1.成都市第三人民医院健康管理中心,四川 成都 610031; 2.陕西省人民医院心血管内一科,陕西 西安 710068)
Author(s):
MEI Lijun; WANG Xiqiang; CUI Qianwei; ZHU Ling; XING Yujie
(Health Management Center,the Third People's Hospital of Chengdu,Chengdu 610031,China)
关键词:
主动脉内球囊反搏;  复杂高危有指征患者;  经皮冠状动脉介入治疗;  心功能;  并发症
Keywords:
Intra-aortic balloon pump;  CHIP;  Percutaneous coronary intervention;  Cardiac function;  Complication
分类号:
R 541.4
DOI:
DOI:10.3969/j.issn.1000-7377.2024.02.018
文献标志码:
A
摘要:
目的:观察主动脉内球囊反搏在复杂高危有指征患者(CHIP)病变介入治疗中的临床疗效。方法:选取62例CHIP病变介入治疗的患者资料进行回顾分析。将经皮冠状动脉介入治疗(PCI)术前保护性植入主动脉内球囊反搏的50例患者设为试验组,未植入主动脉内球囊反搏的12例患者设为对照组,比较两组术中及术后的临床情况。结果:试验组患者术中只有1例发生无复流,1例发生下肢血栓,对照组患者术中有2例发生急性左心衰,1例发生心脏骤停,1例发生无复流。术后试验组N端脑钠肽前体(NT-proBNP)水平较对照组显著降低,且心功能较对照组明显上升,差异均具有统计学意义(均P<0.05)。结论:主动脉内球囊反搏辅助支持下对CHIP病变介入治疗可提高患者的手术安全性,减少手术并发症,有效改善患者心功能。
Abstract:
Objective:To observe the clinical efficacy of intra-aortic balloon pump(IABP)in the interventional treatment of complex high-risk and indicated patients(CHIP)lesions.Methods:A retrospective analysis was conducted on the data of 62 patients with CHIP lesions undergoing interventional therapy.Fifty patients who received protective intra-aortic balloon pump before percutaneous coronary intervention(PCI)were assigned to the experimental group,while 12 patients who did not receive intra-aortic balloon pump were assigned to the control group.The clinical conditions during and after surgery were compared between the two groups.Results:Only one patient in the experimental group experienced no reflow during surgery,and one patient developed lower limb thrombosis.In the control group,two patients experienced acute left heart failure,one experienced cardiac arrest,and one experienced no reflow during surgery.The postoperative NT-proBNP levels in the experimental group were significantly lower than those in the control group,and cardiac function was significantly increased compared to the control group(all P<0.05).Conclusion:Interventional treatment of CHIP lesions with support of IABP can improve the surgical safety,reduce surgical complications,and effectively improve patient cardiac function.

参考文献/References:

[1] JOO M L,JONGHANNE P,JEEHOON K,et al.The efficacy and safety of mechanical hemodynamic support in patients undergoing high-risk percutaneous coronary intervention with or without cardiogenic shock:Bayesian approach network meta-analysis of 13 randomized controlled trials[J].Inter J Cardiol,2014,64(11):19.
[2] AMNEET S,LISA A M,SMITA I N,et al.Use of mechanical circulatory support in patients undergoing percutaneous coronary intervention:Insights from the national cardiovascular data registry[J].Circulation,2015,132(13):1243-1251.
[3] 陈宇,裴宜宾,曹毅,等.体外膜肺氧合联合主动脉内球囊反搏在高危患者经皮冠状动脉介入治疗中的应用[J].中国介入心脏病学杂志,2019,27(4):211-215.
[4] 王睿,陈鑫,徐明,等.术前主动置入主动脉内球囊反搏在极高危冠状动脉旁路移植患者中的应用[J].中华外科杂志,2013,51(9):808-811.
[5] HUA S,YU D,YU J Z.Contemporary management of complex higher-risk and indicated patients:Perspectives from China[J].Chin Med J(Engl),2019,132(12):1387-1389.
[6] VISCUSI M M,MANGIACAPRA F,BRESSI E,et al.Platelet reactivity and clinical outcomes following percutaneous coronary intervention in complex higher-risk patients[J].J Cardiovasc Med(Hagerstown),2022,23(2):135-140.
[7] 田峰,周珊珊,张弢,等.主动脉内球囊反搏联合体外膜肺氧合在急性心肌梗死合并心源性休克患者救治中的应用[J].中国介入心脏病学杂志,2019,27(11):614-618.
[8] DJORDJEVIC I,DEPPE A C,SABASHNIKOV A,et al.Concomitant ecmo and iabp support in postcardiotomy cardiogenic shock patients[J].Heart Lung Circ,2021,30(10):1533-1539.
[9] HUU A L,SHUM-TIM D.Intra-aortic balloon pump:Current evidence & future perspectives[J].Future Cardiol,2018,14(4):319-328.
[10] DE LAZZARI B,CAPOCCIA M,BADAGLIACCA R,et al.Iabp versus impella support in cardiogenic shock:In silico study[J].J Cardiovasc Dev Dis,2023,10(4):140.
[11] 王军红,马青变,郑亚安,等.心脏骤停患者紧急体外膜肺氧合技术的多学科模式探讨[J].中华急诊医学杂志,2017,26(10):1125-1129.
[12] XIE A,PHAN K,TSAI Y, et al.Venoarterial extracorporeal membrane oxygenation for cardiogenic shock and cardia carrest:A meta-analysis[J].J Cardiothorac Vasc Anesth,2017,29(3):637-645.
[13] 兰超,吕青,刘奇,等.体外膜肺氧合对非肺部原发性急诊危重症患者预后影响的Meta 分析[J].中华急诊医学杂志,2018,27(9):1019.
[14] ZEIN R,PATEL C,MERCADO-ALAMO A,et al.A review of the impella devices[J].Interv Cardiol,2022,17:115.
[15] ALUSHI B,DOUEDARI A,FROEHLIG G,et al.Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock[J].Open Heart,2019,6(1):987.
[16] FIORELLI F,PANOULAS V.Impella as unloading strategy during VA-ECMO:Systematic review and meta-analysis[J].Rev Cardiovasc Med,2021,22(4):1503-1511.
[17] 于晓钧,孙欣,曾庆允,等.主动脉内球囊反搏在急性心肌梗死合并心源性休克患者急诊PCI中的应用时机和效果分析[J].广东医学,2018,39(11):1667-1670.
[18] 熊俊.主动脉内球囊反搏对急性心肌梗死合并心源性休克患者的应用效果[J].河南医学研究,2020,29(27):5046-5048.
[19] PARISSIS H,GRAHAM V,LAMPRIDIS S,et al.IABP:History-evolution-pathophysiology-indications:What we need to know?[J].J Cardiothorac Surg,2016,11(1):122.
[20] SOMASCHINI A,CORNARA S,LEONARDI S,et al.Beneficial effects of IABP in anterior myocardial infarction complicated by cardiogenic shock[J].Medicina(Kaunas),2023,59(10):1806.
[21] SALAH K,STIENEN S,PINTO Y M,et al.Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction[J].Heart,2019,105(15):1182-1189.
[22] CAO Z,JIA Y,ZHU B.BNP and NT-proBNP as diagnostic biomarkers for cardiac dysfunction in both clinical and forensic medicine[J].Int J Mol Sci,2019,20(8):1820.
[23] 申文文,延欢欢.不同类型慢性心力衰竭患者血清肌钙蛋白T和N末端B型钠尿肽原水平变化及临床意义[J].陕西医学杂志,2021,50(9):1109-1113.
[24] 任红杰,赵安社,安谊沛,等.芪苈强心胶囊联合西药治疗慢性心力衰竭疗效及对患者 NT-proBNP、hs-CRP、VEGF的影响[J].陕西中医,2019,40(6):711-713.
[25] CUNNINGHAM J W,MYHRE P L.NT-proBNP response to heart failure therapies:An imperfect surrogate[J].J Am Coll Cardiol,2021,78(13):1333-1336.
[26] BERGLER-KLEIN J.NT-proBNP as a cornerstone for prognosis in valve disease:All we need is blood[J].J Am Coll Cardiol,2020,75(14):1673-1675.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金青年科学基金资助项目(81700401); 陕西省卫生健康科研项目(2022B004); 中国博士后科学基金资助面上项目(2022M722576); 陕西省人民医院科技人才支持计划资助项目(2021JY-18)
更新日期/Last Update: 2024-02-05